Marijuana data firm announces $2.5 million capital raise

John Schroyer  | January 19, 2017

One of the cannabis industry’s leading sales data firms announced Wednesday it has secured $2.5 million in private funding to expand its product line.

Seattle-based Headset, which specializes in business intelligence for marijuana-related companies, revealed that it has partnered with Arizona-based Hypur Ventures, a venture capital fund, and Salveo Capital, an Illinois-based private …

Canadian consumer-oriented marijuana firm raises CA$3 million

Omar Sacirbey  | January 19, 2017

A Toronto-based cannabis, coffee and clothing business, Tokyo Smoke, secured 3 million in Canadian dollars ($2.25 million) from investors, claiming it’s the first marijuana-related consumer brand in Canada to raise capital.

The company, which describes itself as a premium cannabis-oriented lifestyle brand, said in a news release that the first-round raise was oversubscribed …

Proposed Florida MMJ rules would prevent new entrants

Bart Schaneman  | January 18, 2017

Maybe there won’t be many business opportunities in Florida’s new medical cannabis industry after all.

State health officials have proposed rules that would give the seven companies currently licensed under Florida’s CBD-focused program entire control of the larger medical marijuana market.

The draft regulations would, in effect, close off the state’s MMJ industry to new growers and …

Brazil allows sale of cannabis-based MS drug

Omar Sacirbey  | January 18, 2017

Brazil’s health care regulator, Anvisa, handed out the nation’s first license for the sale of a cannabis-based drug – one designed for the treatment of multiple sclerosis.

According to Reuters, U.K.-based GW Pharmaceuticals PLC developed the marijuana-based oral spray, which is known internationally as Sativex. It will be marketed in Brazil as Mevatyl.